{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T20:16:32Z","timestamp":1770322592475,"version":"3.49.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fogarty International Center and National Institute on Drug Abuse","award":["D43TW009345-10S2"],"award-info":[{"award-number":["D43TW009345-10S2"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 DA043409"],"award-info":[{"award-number":["R01 DA043409"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12490-1","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:19:08Z","timestamp":1767622748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HIV risk and oral pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID) in Nairobi: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Cosmas","family":"Mugambi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loice","family":"Mbogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Sinkele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Gitau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tecla","family":"Temu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carey","family":"Farquhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bukusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kinuthia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliza","family":"Monroe-Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"3","key":"12490_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2991\/jegh.k.210621.001","volume":"11","author":"RD Govender","year":"2021","unstructured":"Govender RD, Hashim MJ, Khan MA, Mustafa H, Khan G. Global epidemiology of HIV\/AIDS: A resurgence in North America and Europe. J Epidemiol Glob Health. 2021;11(3):296\u2013301. https:\/\/doi.org\/10.2991\/jegh.k.210621.001. Epub 2021 Jun 29. PMID: 34270183; PMCID: PMC8435868.","journal-title":"J Epidemiol Glob Health"},{"key":"12490_CR2","unstructured":"United Nations Office on Drugs and Crime. World drug report 2021 (United Nations publication, Sales No. E.21.XI.8)."},{"key":"12490_CR3","unstructured":"UNAIDS. Miles to go: closing gaps, breaking barriers, fighting injustices. 2018. Accessed on 22nd July 2022 at: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/miles-to-go_en.pdf."},{"key":"12490_CR4","unstructured":"National Syndemic Diseases Control Council. 2024. HIV estimates portal. Accessed on 31st. October 2024. https:\/\/analytics.nsdcc.go.ke\/estimates\/#!\/kenya\/overview."},{"key":"12490_CR5","unstructured":"National AIDS Control Council (NACC). Kenya HIV estimates report 2018. 2019. Accessed on 22nd July 2022 at: http:\/\/nacc.or.ke\/wp-content\/uploads\/2018\/11\/HIV-estimates-report-Kenya-20182.pdf."},{"key":"12490_CR6","unstructured":"National Authority for the Campaign Against Alcohol and Drug Abuse (NACADA). Rapid situation assessment of the status of drug and substance abuse national commission against drug abuse, Kenya. 2012. Accessed on 22nd July 2022 at: <16\/10\/2020 at: https:\/\/nacada.go.ke\/node\/157."},{"issue":"1","key":"12490_CR7","doi-asserted-by":"publisher","first-page":"21856","DOI":"10.7448\/IAS.20.1.21856","volume":"20","author":"Z Mohamed","year":"2017","unstructured":"Mohamed Z, Mbwambo J, Shimakawa Y, et al. Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania. J Int AIDS Soc. 2017;20(1):21856. PMID: 28953324; PMCID: PMC5964737.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"12490_CR8","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1111\/jvh.12966","volume":"25","author":"Z Mohamed","year":"2018","unstructured":"Mohamed Z, Rwegasha J, Kim JU, et al. The hepatitis C cascade of care in people who inject drugs in Dar Es Salaam, Tanzania. J Viral Hepat. 2018;25(12):1438\u201345. https:\/\/doi.org\/10.1111\/jvh.12966. Epub 2018 Jul 30. PMID: 29974582; PMCID: PMC6282511.","journal-title":"J Viral Hepat"},{"key":"12490_CR9","unstructured":"National Key Populations Programme (NASCOP). 2010\u20132011, integrated biological and behavioural surveillance survey among key populations in Nairobi and Kisumu, Kenya. Nairobi: NASCOP, Ministry of Health, Kenya. 2014. Accessed on 22nd July 2022 at: https:\/\/globalhealthsciences.ucsf.edu\/sites\/globalhealthsciences.ucsf.edu\/files\/pub\/final_report_keypops_ibbs_nov_24_2014_print.pdf."},{"key":"12490_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.drugpo.2017.09.012","volume":"51","author":"J Tiberio","year":"2018","unstructured":"Tiberio J, Laurent YI, Ndayongeje J, et al. Context and characteristics of illicit drug use in coastal and interior Tanzania. Int J Drug Policy. 2018;51:20\u20136.","journal-title":"Int J Drug Policy"},{"key":"12490_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.drugalcdep.2015.02.037","volume":"151","author":"JL Syvertsen","year":"2015","unstructured":"Syvertsen JL, Agot K, Ohaga S, et al. Evidence of injection drug use in Kisumu, kenya: implications for HIV prevention. Drug Alcohol Depend. 2015;151:262\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"12490_CR12","unstructured":"National AIDS, Control Programme STI. (NASCOP). Key population mapping and size estimation in selected counties in Kenya: phase 1 key findings. 2019. http:\/\/hivpreventioncoalition.unaids.org\/wp-content\/uploads\/2020\/02\/KPSE-Phase1-Final-Report.pdf."},{"key":"12490_CR13","unstructured":"Centers for Disease Control and Prevention. PrEP. Accessed 8th. May 2022 at: http:\/\/www.cdc.gov\/hiv\/basics\/prep.html."},{"issue":"Iss 2","key":"12490_CR14","first-page":"Article5","volume":"3","author":"D Egorova","year":"2021","unstructured":"Egorova D, Fenton A, Thakarar K. Factors that influence perception of HIV risk and willingness to use Pre-Exposure prophylaxis in people who inject drugs. J Maine Med Cent. 2021;3(Iss 2):Article5.","journal-title":"J Maine Med Cent"},{"issue":"9883","key":"12490_CR15","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083\u201390.","journal-title":"Lancet"},{"key":"12490_CR16","volume-title":"STI control programme (NASCOP), ministry of Health. Framework for the implementation of pre-exposure prophylaxis of HIV in Kenya","author":"AIDS National","year":"2017","unstructured":"National AIDS. STI control programme (NASCOP), ministry of Health. Framework for the implementation of pre-exposure prophylaxis of HIV in Kenya. Nairobi: NASCOP; 2017. Accessed on 17th July 2022 at: <. http:\/\/www.prepwatch.org\/wp-content\/uploads\/2017\/05\/Kenya_PrEP_Implementation_Framework.pdf%3E."},{"key":"12490_CR17","unstructured":"Boston University. Low PrEP knowledge among people who inject drugs. 2019. Retrieved on 6th February 2025 at: http:\/\/www.bu.edu\/sph\/news\/articles\/2018\/low-prep-knowledge-among-people-who-inject-drugs\/."},{"key":"12490_CR18","doi-asserted-by":"publisher","unstructured":"Bazzi AR, Biancarelli DL, Childs E, et al. Correction to: AIDS patient care and STDs, 2018;32:306\u2013313; https:\/\/doi.org\/10.1089\/apc.2018.0028. AIDS Patient Care and STDs. Dec 2018.529-537.","DOI":"10.1089\/apc.2018.0028"},{"key":"12490_CR19","doi-asserted-by":"publisher","unstructured":"Mistlera CB, Copenhavera MM, Shrestha R The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: a systematic review. AIDS Behav. 2021;25(5):1490\u20131506. https:\/\/doi.org\/10.1007\/s10461-020-02988-x. PMID: 32749627; PMCID: PMC7858689.","DOI":"10.1007\/s10461-020-02988-x"},{"issue":"1","key":"12490_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12954-018-0263-5","volume":"15","author":"KB Biello","year":"2018","unstructured":"Biello KB, Bazzi AR, Mimiaga MJ, et al. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J. 2018;15(1):55.","journal-title":"Harm Reduct J"},{"key":"12490_CR21","doi-asserted-by":"publisher","unstructured":"Roth AM, Tran NK, Felsher M, et al. Integrating HIV preexposure prophylaxis with Community-Based syringe services for women who inject drugs: results from the project SHE demonstration study. JAIDS J Acq Immun Defici Syndrom. 2021 Mar 1;86(3):e61\u201370. https:\/\/doi.org\/10.1097\/QAI.0000000000002558.","DOI":"10.1097\/QAI.0000000000002558"},{"issue":"4","key":"12490_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/01.aids.0000161772.51900.eb","volume":"19","author":"LI Gardner","year":"2005","unstructured":"Gardner LI, Metsch LR, Anderson-Mahoney P, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. Aids. 2005;19(4):423\u201331.","journal-title":"Aids"},{"issue":"3","key":"12490_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.drugalcdep.2005.11.015","volume":"83","author":"SA Strathdee","year":"2006","unstructured":"Strathdee SA, Ricketts EP, Huettner S, et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: results from a community-based behavioral intervention trial. Drug Alcohol. 2006;83(3):225\u201332.","journal-title":"Drug Alcohol"},{"key":"12490_CR24","doi-asserted-by":"publisher","first-page":"232595821984884","DOI":"10.1177\/2325958219848848","volume":"18","author":"S Doblecki-Lewis","year":"2019","unstructured":"Doblecki-Lewis S, Butts S, Botero V, et al. A randomized study of passive versus active PrEP patient navigation for a heterogeneous population at risk for HIV in South Florida. J Int Assoc Provid AIDS Care. 2019;18:2325958219848848.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"9","key":"12490_CR25","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1097\/QAD.0000000000002230","volume":"33","author":"JH Samet","year":"2019","unstructured":"Samet JH, Blokhina E, Cheng DM, et al. A strengths-based case management intervention to link HIV-positive people who inject drugs in Russia to HIV care. Aids. 2019;33(9):1467\u201376.","journal-title":"Aids"},{"key":"12490_CR26","doi-asserted-by":"crossref","unstructured":"Gardner LI, Metsch LR, Anderson-Mahoney P et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. Aids. 2005;19(4):423\u2013431.","DOI":"10.1097\/01.aids.0000161772.51900.eb"},{"key":"12490_CR27","doi-asserted-by":"crossref","unstructured":"Strathdee SA, Ricketts EP, Huettner S, et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: results from a community-based behavioral intervention trial. Drug Alcohol. 2006;83(3):225\u2013232.","DOI":"10.1016\/j.drugalcdep.2005.11.015"},{"key":"12490_CR28","doi-asserted-by":"crossref","unstructured":"Doblecki-Lewis S, Butts S, Botero V et al. A randomized study of passive versus active PrEP patient navigation for a heterogeneous population at risk for HIV in South Florida. J Int Assoc Provid AIDS Care. 2019;18:2325958219848848.","DOI":"10.1177\/2325958219848848"},{"key":"12490_CR29","doi-asserted-by":"crossref","unstructured":"Samet JH, Blokhina E, Cheng DM, et al. A strengths-based case management intervention to link HIV-positive people who inject drugs in Russia to HIV care. Aids. 2019;33(9):1467\u20131476.","DOI":"10.1097\/QAD.0000000000002230"},{"key":"12490_CR30","unstructured":"Rosner B. Fundamentals of biostatistics. 7th education. Boston, MA: Brooks\/Cole; 2011."},{"key":"12490_CR31","unstructured":"Ministry of Health. Kenya HIV estimates report 2018. 2019. Accessed on 22nd July 2022 at: http:\/\/nacc.or.ke\/wp-content\/uploads\/2018\/11\/HIV-estimates-report-Kenya-20182.pdf."},{"key":"12490_CR32","unstructured":"Ministry of Health, National AIDS &STI Control Programme. Pre-exposure prophylaxis for the prevention of HIV infection, a toolkit for health service providers, Nairobi, Kenya: NASCOP.2017. Accessed on 22nd. July 2022: http:\/\/prep.nascop.org\/wp-content\/uploads\/sites\/2\/2019\/03\/PrEP-for-the-prevention-of-HIV_-A-Toolkit-for-Providers.pdf."},{"key":"12490_CR33","unstructured":"Federal Drug Authority. OraQuick Rapid HIV-1 Antibody Test Questions and Answers. 2018. Accessed on 4th May 2022 at: https:\/\/www.fda.gov\/vaccines-blood-biologics\/approved-blood-products\/oraquick-rapid-hiv-1-antibody-test-questions-and-answers#:~:text=What%20is%20the%20OraQuick%20Rapid,a%20fingerstick%20sample%20of%20blood."},{"key":"12490_CR34","unstructured":"Ministry of Health, National AIDS &STI Control Programme. Pre-exposure prophylaxis for the prevention of HIV infection, a toolkit for health service providers, Nairobi, Kenya: NASCOP. 2017. Accessed on 17th June 2022 at: http:\/\/prep.nascop.org\/wp-content\/uploads\/sites\/2\/2019\/03\/PrEP-for-the-prevention-of-HIV_-A-Toolkit-for-Providers.pdf."},{"key":"12490_CR35","unstructured":"Ward J, Darke S, Hall W. The HIV risk-taking behaviour scale (HRBS) manual. Nat Drug Alcohol Res Centre. 1990. Technical Report Number 10 ISBN 0 947 229 19 1."},{"key":"12490_CR36","doi-asserted-by":"crossref","unstructured":"McFarland W, Lin J, Santos GM, et al. Low PrEP awareness and use among people who inject drugs, San Francisco, 2018. AIDS and Behavior. 2019.","DOI":"10.1007\/s10461-019-02682-7"},{"key":"12490_CR37","unstructured":"Hauwei Technologies Co. Ltd. Huawei Media Pad (T3 7.0) Tablet. Accessed on 22nd June 2022 at: http:\/\/www.gsmarena.com\/huawei_mediapad_t3_7_0-8635.php."},{"key":"12490_CR38","unstructured":"Kobo Inc. KoBoToolbox. Accessed on 22nd June 2022 at: https:\/\/www.kobotoolbox.org\/."},{"issue":"4","key":"12490_CR39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/QAI.0000000000000769","volume":"70","author":"AE Kurth","year":"2015","unstructured":"Kurth AE, Cleland CM, Jarlais DC, Et. HIV Prevalence, estimated Incidence, and risk behaviors among people who inject drugs in Kenya. J Acquir Immune Defic Syndr. 2015;70(4):420\u20137. https:\/\/doi.org\/10.1097\/QAI.0000000000000769.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"12490_CR40","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1186\/s12889-021-11373-9","volume":"21","author":"F Oguya","year":"2021","unstructured":"Oguya F, Kenya P, Ongecha F, et al. Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of kenya: a respondent driven sampling survey. BMC Public Health. 2021;21:1549. https:\/\/doi.org\/10.1186\/s12889-021-11373-9.","journal-title":"BMC Public Health"},{"key":"12490_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12954-019-0281-y","volume":"16","author":"G Mburu","year":"2019","unstructured":"Mburu G, Limmer M, Holland P. HIV risk behaviours among women who inject drugs in coastal kenya: findings from secondary analysis of qualitative data. Harm Reduct J. 2019;16:10. https:\/\/doi.org\/10.1186\/s12954-019-0281-y.","journal-title":"Harm Reduct J"},{"key":"12490_CR42","unstructured":"National AIDS, Control Council. Kenya HIV county profiles 2016. 2017. Accessed on 22nd July 2022 at: https:\/\/nacc.or.ke\/wp-content\/uploads\/2016\/12\/Kenya-HIV-County-Profiles-2016.pdf."},{"key":"12490_CR43","unstructured":"Ministry of Health. Kenya\u2019s fast-track plan to end HIV and AIDS among adolescents and young people. 2015. Accessed on July 2nd 2022 at: http:\/\/lvcthealth.org\/wp-content\/uploads\/2017\/09\/fast-track-plan-to-end-adolescent-aids-and-stigma-fastrack.pdf."},{"key":"12490_CR44","unstructured":"Ministry of Health. Kenya AIDS strategic framework 2014\/2015\u20132018\/2019.2014. Accessed on 2nd July 2022 at: http:\/\/nacc.or.ke\/wp-content\/uploads\/2015\/09\/KASF_Final.pdf."},{"issue":"5","key":"12490_CR45","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1177\/0956462420912141","volume":"31","author":"ER Begnel","year":"2020","unstructured":"Begnel ER, Escudero J, Mugambi M, et al. High pre-exposure prophylaxis awareness and willingness to pay for pre-exposure prophylaxis among young adults in Western kenya: results from a population-based survey. Int J STD AIDS. 2020;31(5):454\u20139. https:\/\/doi.org\/10.1177\/0956462420912141.","journal-title":"Int J STD AIDS"},{"key":"12490_CR46","unstructured":"Ministry of Health, Kenya. 2020. Kenya AIDS strategic framework II, 2020\/21-2024\/25. https:\/\/nsdcc.go.ke\/wp-content\/uploads\/2021\/01\/KASFII_Web22.pdf."},{"issue":"8","key":"12490_CR47","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1089\/apc.2020.0037","volume":"34","author":"J Sila","year":"2020","unstructured":"Sila J, Larsen AM, Kinuthia J, et al. High Awareness, yet low Uptake, of Pre-Exposure prophylaxis among adolescent girls and young women within family planning clinics in Kenya. AIDS Patient Care STDS. 2020;34(8):336\u201343. https:\/\/doi.org\/10.1089\/apc.2020.0037. PMID: 32757980; PMCID: PMC7415219.","journal-title":"AIDS Patient Care STDS"},{"key":"12490_CR48","doi-asserted-by":"publisher","unstructured":"Corcorran MA, Scott JD, Tinsley J, et al. Awareness and correlates of HIV pre-exposure prophylaxis (PrEP) among HIV-negative people who access syringe services in Seattle, Washington, Substance Use & Misuse, 2022: 57:3, 337\u2013343. https:\/\/doi.org\/10.1080\/10826084.2021.2012688.","DOI":"10.1080\/10826084.2021.2012688"},{"issue":"4","key":"12490_CR49","doi-asserted-by":"publisher","first-page":"e0231424","DOI":"10.1371\/journal.pone.0231424","volume":"15","author":"Y Jo","year":"2020","unstructured":"Jo Y, Bartholomew TS, Doblecki-Lewis S, et al. Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida. PLoS ONE. 2020;15(4):e0231424. https:\/\/doi.org\/10.1371\/journal.pone.0231424.","journal-title":"PLoS ONE"},{"issue":"2","key":"12490_CR50","doi-asserted-by":"publisher","first-page":"e0247352","DOI":"10.1371\/journal.pone.0247352","volume":"16","author":"A Belludi","year":"2022","unstructured":"Belludi A, McFall AM, Solomon SS, et al. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in india: results from a multi-city cross-sectional survey. PLoS ONE. 2022;16(2):e0247352. https:\/\/doi.org\/10.1371\/journal.pone.0247352.","journal-title":"PLoS ONE"},{"issue":"3","key":"12490_CR51","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s40121-017-0159-9","volume":"6","author":"JL Bailey","year":"2017","unstructured":"Bailey JL, Molino ST, Vega AD, et al. A review of HIV Pre-Exposure prophylaxis: the female perspective. Infect Dis Therapy. 2017;6(3):363\u201382. https:\/\/doi.org\/10.1007\/s40121-017-0159-9.","journal-title":"Infect Dis Therapy"},{"issue":"6","key":"12490_CR52","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/13691058.2015.1101786","volume":"18","author":"M Hartmann","year":"2016","unstructured":"Hartmann M, Montgomery E, Stadler J, et al. Negotiating the use of female-initiated HIV prevention methods in a context of gender-based violence: the narrative of rape. Cult Health Sex. 2016;18(6):611\u201324.","journal-title":"Cult Health Sex"},{"key":"12490_CR53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/women1020011","volume":"1","author":"C Alina","year":"2021","unstructured":"Alina C, Crystal W, Drew A, et al. Changing the PrEP narrative: A call to action to increase PrEP uptake among women. Women. 2021;1:120\u20137. https:\/\/doi.org\/10.3390\/women1020011.","journal-title":"Women"},{"issue":"6","key":"12490_CR54","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/09540121.2020.1822506","volume":"33","author":"KE Schneider","year":"2021","unstructured":"Schneider KE, White RH, O\u2019Rourke A, et al. Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia. AIDS Care. 2021;33(6):721\u20138. Epub 2020 Sep 21. PMID: 32951438; PMCID: PMC7981279.","journal-title":"AIDS Care"},{"key":"12490_CR55","unstructured":"Green KE, Huong PTT, Bao VN. Acceptability of and willingness to pay for long-acting injectable pre-exposure prophylaxis among men who have sex with men, transgender women, female sex workers and people who inject drugs in Vietnam. 2021. Accessed on 30th June 2022 at: https:\/\/pdf.usaid.gov\/pdf_docs\/PA00ZBHX.pdf."},{"issue":"1","key":"12490_CR56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11524-020-00494-y","volume":"98","author":"SM Walters","year":"2021","unstructured":"Walters SM, Kral AH, Lamb S et al. Correlates of transactional sex and violent victimization among men who inject drugs in Los Angeles and San Francisco, California. J Urb Health, 2021: 98:1, 70\u201382.","journal-title":"J Urb Health"},{"issue":"1","key":"12490_CR57","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12954-017-0166-x","volume":"14","author":"SM Walters","year":"2021","unstructured":"Walters SM, Reilly KH, Neaigus A et al. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduct J,2021, 14(1), 40.","journal-title":"Harm Reduct J"},{"issue":"1","key":"12490_CR58","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s12889-024-17965-5","volume":"24","author":"TC Willie","year":"2024","unstructured":"Willie TC, Linton SL, Whittaker S, Phillips KA, Knight D, Gray MC, Gardner G, Overstreet NM. Housing insecurity among black women surviving intimate partner violence during the COVID-19 pandemic: an intersectional qualitative approach. BMC Public Health. 2024;24(1):501.","journal-title":"BMC Public Health"},{"issue":"10","key":"12490_CR59","first-page":"1632","volume":"55","author":"KE Lancaster","year":"2020","unstructured":"Lancaster KE, Cooper HLF, Browning CR, Malvestutto CD, Bridges JFP, Young AM. Syringe service program utilization, barriers, and preferences for design in rural appalachia: differences between men and women who inject drugs. Subst Use Misuse. 2020;55(10):1632\u201341.","journal-title":"Subst Use Misuse"},{"key":"12490_CR60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13011-020-00331-0","volume":"15","author":"SM Przybyla","year":"2020","unstructured":"Przybyla SM, Cerulli C, Bleasdale J, et al. I think everybody should take it if they\u2019re doing drugs, doing heroin, or having sex for money: a qualitative study exploring perceptions of pre-exposure prophylaxis among female participants in an opioid intervention court program. Subst Abuse Treat Prev Policy. 2020;15:89.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"6","key":"12490_CR61","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1521\/aeap.2020.32.6.486","volume":"32","author":"M Felsher","year":"2020","unstructured":"Felsher M, Bellamy S, Piecara B, Van Der Pol B, Laurano R, Roth AM. Applying the behavioral model for vulnerable populations to Pre-Exposure prophylaxis initiation among women who inject drugs. AIDS Educ Prev. 2020;32(6):486\u201392. PMID: 33779207; PMCID: PMC8010910.","journal-title":"AIDS Educ Prev"},{"key":"12490_CR62","doi-asserted-by":"publisher","unstructured":"Glick JL, Russo R, Jivapong B, Rosman L, Pelaez D, Footer KHA, Sherman SG. The PrEP care continuum among cisgender women who sell sex and\/or use drugs globally: a systematic review. AIDS Behav. 2020;24(5):1312\u201333. https:\/\/doi.org\/10.1007\/s10461-019-02733-z. PMID: 31807973; PMCID: PMC7899785.","DOI":"10.1007\/s10461-019-02733-z"},{"issue":"2","key":"12490_CR63","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1521\/aeap.2021.33.2.103","volume":"33","author":"M Hartmann","year":"2021","unstructured":"Hartmann M, Otticha S, Agot K, et al. Tu\u2019Washindi Na prep: working with young women and service providers to design an intervention for PrEP uptake and adherence in the context of Gender-Based violence. AIDS Educ Prevention: Official Publication Int Soc AIDS Educ. 2021;33(2):103\u201319. https:\/\/doi.org\/10.1521\/aeap.2021.33.2.103.","journal-title":"AIDS Educ Prevention: Official Publication Int Soc AIDS Educ"},{"issue":"1","key":"12490_CR64","doi-asserted-by":"publisher","first-page":"1886455","DOI":"10.1080\/16549716.2021.1886455","volume":"14","author":"S Shamu","year":"2021","unstructured":"Shamu S, Shamu P, Khupakonke S, et al. Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African districts. Glob Health Action. 2021;14(1):1886455. PMID: 33606603; PMCID: PMC7899653.","journal-title":"Glob Health Action"},{"issue":"2","key":"12490_CR65","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11904-018-0385-0","volume":"15","author":"SA Golub","year":"2018","unstructured":"Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV\/AIDS Rep. 2018;15(2):190\u20137. https:\/\/doi.org\/10.1007\/s11904-018-0385-0. PMID: 29460223; PMCID: PMC5884731.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"8","key":"12490_CR66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1089\/apc.2021.0084","volume":"35","author":"PK Valente","year":"2021","unstructured":"Valente PK, Mimiaga MJ, Chan PA, Biello KB. Health Service- and Provider-Level factors influencing engagement in HIV Pre-Exposure prophylaxis care among male sex workers. AIDS Patient Care STDS. 2021;35(8):279\u201387. PMID: 34375139; PMCID: PMC8380801.","journal-title":"AIDS Patient Care STDS"},{"key":"12490_CR67","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1186\/s12889-021-11335-1","volume":"21","author":"M Jackson-Gibson","year":"2021","unstructured":"Jackson-Gibson M, Ezema AU, Orero W, et al. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in seme Sub-County, Kisumu, Kenya. BMC Public Health. 2021;21:1284. https:\/\/doi.org\/10.1186\/s12889-021-11335-1.","journal-title":"BMC Public Health"},{"issue":"5","key":"12490_CR68","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10461-016-1627-z","volume":"21","author":"FM Koechlin","year":"2017","unstructured":"Koechlin FM, Fonner VA, Dalglish SL, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21(5):1325\u201335. https:\/\/doi.org\/10.1007\/s10461-016-1627-z.","journal-title":"AIDS Behav"},{"issue":"2","key":"12490_CR69","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1089\/apc.2014.0142","volume":"29","author":"JD Auerbach","year":"2015","unstructured":"Auerbach JD, Kinsky S, Brown G, et al. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDS. 2015;29(2):102\u201310. https:\/\/doi.org\/10.1089\/apc.2014.0142.","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"12490_CR70","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","volume":"37","author":"KH Mayer","year":"2020","unstructured":"Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of Pre-exposure prophylaxis in the united states: A narrative review. Adv Therapy. 2020;37(5):1778\u2013811. https:\/\/doi.org\/10.1007\/s12325-020-01295-0.","journal-title":"Adv Therapy"},{"issue":"6","key":"12490_CR71","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1007\/s10461-019-02767-3","volume":"24","author":"ST Allen","year":"2020","unstructured":"Allen ST, O\u2019Rourke A, White RH, Smith KC, Weir B, Lucas GM, Sherman SG, Grieb SM. Barriers and facilitators to PrEP use among people who inject drugs in rural appalachia: A qualitative study. AIDS Behav. 2020;24(6):1942\u201350. https:\/\/doi.org\/10.1007\/s10461-019-02767-3.","journal-title":"AIDS Behav"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12490-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12490-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12490-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:47:55Z","timestamp":1770281275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12490-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12490"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12490-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. Ethical approval was obtained from Kenyatta National Hospital (KNH) and the University of Nairobi (UON) Ethical Committee (ERC) and the University of Washington\u2019s Human Subjects Division while administrative approval was obtained from the National Commission for Science, Technology, and Innovation (NACOSTI) in Kenya. Written informed consent was obtained from all the adult participants prior to enrolment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}